RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2006228026 (hide)

Owner Sirna Therapeutics, Inc.

Inventors Macejak, Dennis; Morrissey, David; Beigelman, Leonid; McSwiggen, James

Agent Spruson & Ferguson

Pub. Number AU-A-2006228026

Parent 2003219817

Filing date 11 October 2006

Wipo publication date 2 November 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

26 October 2006 Complete Application Filed

2 November 2006 Application Open to Public Inspection

  Published as AU-A-2006228026

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228027-delta-crystalline of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

2006228025-Air conditioner